SCHEMBL14917475

SCHEMBL14917475

NC(=O)c1cc(F)c(-c2ccccc2)nc1N

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 4/20 0.51
CDC7 O00311 2/20 0.48
RCE1 Q9Y256 1/20 0.46
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
BCAT2 O15382 1/20 0.42
BRD4 O60885 1/20 0.42
MAPK1 P28482 1/20 0.42
PLAU P00749 2/20 0.41
PARP1 P09874 1/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
CASP1 P29466 1/20 0.41
DHODH Q02127 2/20 0.41
CHUK O15111 1/20 0.40
IKBKE Q14164 1/20 0.40
PKMYT1 Q99640 1/20 0.40
MAP4K4 O95819 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14917452 0.84 MKNK1 (0.52) IKBKBCDC7KMT2A
SCHEMBL27824724 0.75 RCE1 (0.52) IKBKBRCE1KDM4EBCAT2BRD4
SCHEMBL18049029 0.75 IKBKB (0.48) IKBKBCDC7RCE1BRD4PARP1
SCHEMBL11906705 0.73 DHODH (0.45) KDM4EALDH1A1MAPK1PLAUGAA
SCHEMBL4782645 0.72 BCAT2 (0.46) IKBKBCDC7KDM4EALDH1A1BCAT2
SCHEMBL14917463 0.70 MEN1 (0.62) IKBKBKDM4EALDH1A1BCAT2PARP1
SCHEMBL6765797 0.70 CDC7 (0.55) IKBKBCDC7MAPK1CHUKIKBKE
SCHEMBL18229940 0.70 IKBKB (0.48) IKBKBCDC7KDM4EALDH1A1BCAT2
SCHEMBL16465321 0.70 KMT2A (0.45) IKBKBCDC7KDM4EALDH1A1PLAU
SCHEMBL28783782 0.70 AKR1C2 (0.45) KDM4EALDH1A1MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK IKBKB 217/4885CDC7 4368/4885RCE1 4376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.